Replies to post #76101 on Bioelectronics Corp (BIEL)

[uksausage]

interesting that the accountant is probably in more trouble than the Whelans.

I assume they will have a new accountant for Q1.

R&D expense is a core line that has to be maintained. Items like smart insole are an example of how the product line can be expanded and when the target market for each solution is counted in the 10's of millions the return on R&D will be immense once the market is open.